Verastem, Inc.

URI: https://gptkb.org/entity/Verastem%2C_Inc.
GPTKB entity
Statements (47)
Predicate Object
gptkbp:instance_of gptkb:Company
gptkbp:acquisition gptkb:collaboration
gptkb:Coh_Bar,_Inc.
gptkb:2018
gptkbp:ceo gptkb:Robert_Forrester
gptkbp:clinical_trial gptkb:Europe
gptkb:Asia
gptkb:Australia
gptkb:United_States
gptkb:Native_American_tribe
Phase 3
Phase 1/2 trial
gptkbp:collaborations gptkb:European_Organization_for_Research_and_Treatment_of_Cancer
gptkb:healthcare_organization
gptkb:Duke_University
gptkb:Johns_Hopkins_University
gptkb:Massachusetts_Institute_of_Technology
gptkb:University_of_California,_San_Francisco
gptkb:Cancer_Research_UK
gptkb:Research_Institute
gptkbp:employees 51-200
gptkbp:focus cancer therapeutics
gptkbp:founded gptkb:2010
gptkbp:founder gptkb:Robert_Forrester
gptkbp:headquarters gptkb:Needham,_Massachusetts
gptkbp:healthcare gptkb:2018
https://www.w3.org/2000/01/rdf-schema#label Verastem, Inc.
gptkbp:investment gptkb:New_Enterprise_Associates
gptkb:Sofinnova_Partners
gptkb:Bessemer_Venture_Partners
gptkb:Canaan_Partners
gptkbp:location gptkb:United_States
gptkbp:partnership gptkb:temple
Merck K Ga A
gptkbp:products gptkb:Duvelisib
gptkb:VS-5584
gptkb:VS-6766
gptkbp:research_areas oncology
gptkbp:research_focus P I3 K pathway
Raf/ MEK pathway
gptkbp:stock_exchange gptkb:NASDAQ
gptkbp:symbol VSTM
gptkbp:traded_on gptkb:NASDAQ
gptkbp:type gptkb:Company
gptkbp:website www.verastem.com
gptkbp:bfsParent gptkb:duvelisib
gptkbp:bfsLayer 5